ArticleThe Indian journal of medical research2026
Chronic kidney disease in India: Incidence, prevalence, mortality, DALYs, and State-level disparities, 1990-2023.
Article in The Indian journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objectives Chronic kidney disease (CKD) is a major non-communicable cause of premature mortality and disability in India, yet no study has systematically evaluated the State-level trajectories and inequalities underpinning its burden. Methods We extracted age-standardised incidence, prevalence, mortality, and disability-adjusted life-years (DALY) estimates for CKD (ICD-10: N18-N19) from the global burden of disease (GBD) 2023 database for the period 1990-2023. Estimated annual percentage change (EAPC) was calculated using log-linear regression. States were classified into clusters based on burden relative to the national age-standardised rate and trend direction. Socioeconomic gradients were assessed using the socio-demographic index (SDI), concentration curves, and concentration indices. Uncertainty intervals (UIs) were incorporated. Results In 2023, across Indian States the incidence ranged from 226.4 to 316.4 per 100,000, prevalence from 10,452 to 12,539 per 100,000, mortality from 6.71 to 19.84 per 100,000, and DALYs from 312.2 to 666.4 per 100,000. National EAPCs showed declining trends for incidence (-0.45%), prevalence (-0.22%), mortality (-0.90%), and DALYs (-1.10%). However, high-burden States such as Telangana and Punjab had sustained elevated mortality and DALYs despite declining trends. Concentration indices demonstrated significant pro-poor inequality for mortality [confidence interval (CI) -0.12] and DALYs (CI -0.24). Locally estimated scatterplot smoothing (LOESS) models revealed non-linear SDI relationships, with high-SDI States achieving lower mortality but persistent high prevalence. Interpretations and conclusions CKD poses a substantial and unequal burden across India, with widening disparities in mortality and disability. Targeted State-level interventions, early detection programmes, and equitable renal care infrastructure are urgently needed to reduce geographic inequity and achieve national NCD targets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.